Evaluation of Therapeutic Equivalence
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
July 21, 2022
January 11, 2023
cd67148c-495a-4ce8-be79-e37f4769b3ae
Related Documents
New Clinical Investigation Exclusivity (3-Year Exclusivity) for Drug Products: Questions and Answers
Guidance DocumentMarch 3, 2026Center for Drug Evaluation and Research
Sameness Evaluations in an ANDA — Active Ingredients
Guidance DocumentNovember 8, 2022Center for Drug Evaluation and Research
In Vitro Release Test Studies for Topical Drug Products Submitted in ANDAs
Guidance DocumentOctober 21, 2022Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Stay ahead of FDA enforcement
New KeyPedia insights, webinars, and regulatory analysis — straight to your inbox. Unsubscribe anytime.